Balentine LLC Astrazeneca PLC Transaction History

Balentine LLC

$2.54 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $324,862 - $370,321	5,323 Added 39.45%	18,815 $1.27 Million
Q4 2023 Feb 09, 2024	BUY	$61.89 - $69.28 $533,553 - $597,262	8,621 Added 176.99%	13,492 $908,000
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $16,666 - $18,426	-257 Reduced 5.01%	4,871 $329,000
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $18,456 - $20,013	264 Added 5.43%	5,128 $367,000
Q1 2023 May 11, 2023	BUY	$63.15 - $71.6 $1,705 - $1,933	27 Added 0.56%	4,864 $337,000
Q4 2022 Jan 31, 2023	SELL	$54.21 - $70.44 $48,409 - $62,902	-893 Reduced 15.58%	4,837 $327,000
Q3 2022 Oct 26, 2022	SELL	$53.02 - $135.75 $145,062 - $371,412	-2,736 Reduced 32.32%	5,730 $314,000
Q2 2022 Oct 26, 2022	SELL	$59.26 - $71.14 $272,477 - $327,101	-4,598 Reduced 35.2%	8,466 $559,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $501,695 - $602,271	8,466 New	8,466 $559,000
Q1 2022 Oct 26, 2022	BUY	$55.72 - $67.12 $256,200 - $308,617	4,598 Added 54.31%	13,064 $867,000
Q4 2021 Oct 26, 2022	SELL	$54.02 - $63.83 $64,878 - $76,659	-1,201 Reduced 14.19%	7,265 $423,000
Q4 2021 Feb 02, 2022	SELL	$54.02 - $63.83 $319,420 - $377,426	-5,913 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $12,501 - $13,677	-225 Reduced 3.67%	5,913 $355,000
Q2 2021 Aug 16, 2021	BUY	$48.42 - $60.18 $297,201 - $369,384	6,138 New	6,138 $368,000
Q3 2020 Nov 02, 2020	SELL	$53.07 - $61.1 $108,846 - $125,316	-2,051 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $88,398 - $113,440	2,051 New	2,051 $108,000
Q4 2019 Sep 02, 2020	SELL	$42.46 - $50.46 $56,556 - $67,212	-1,332 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $6,337 - $7,085	170 Added 14.63%	1,332 $55,000
Q1 2019 May 16, 2019	BUY	$35.49 - $43.02 $18,277 - $22,155	515 Added 79.6%	1,162 $47,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $5,804 - $6,633	167 Added 34.79%	647 $26,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $16,584 - $17,784	480 New	480 $17,000
Q1 2018 May 16, 2018	SELL	$32.97 - $36.63 $49,059 - $54,505	-1,488 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$32.09 - $34.78 $1,155 - $1,252	-36 Reduced 2.36%	1,488 $52,000
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $44,135 - $51,816	1,524	1,524 $52,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account